ROEHNRX

Age Verification

This website contains content related to pharmaceutical research compounds. You must be 18 years or older to proceed.

By entering you agree to our Terms of Service

Your Cart

Your cart is empty

Browse ProductsBrowse Products
BPC-157

regenerative

BPC-157

Gastrointestinal Repair & ProtectionTissue Repair

A stable pentadecapeptide originally isolated from human gastric juice, recognized in preclinical research for its broad-spectrum regenerative activity across musculoskeletal, gastrointestinal, and neurological tissue systems.

For research and laboratory use only. Not for human consumption.

$120
Auto-Replenish
$120
Save 15%
One-Time Purchase
$141

Subscribe & save: $120

Quantity

1

Add 1 more to save 10% per unit

Upgrade to Stack

Recovery Stack
Save $3
BPC-157
TB-500
$517$520
View Details

Technical Data

Specifications

Specifications

Technical Details

01
Purity≥99% (HPLC)
02
FormLyophilized Powder
03
StorageStore at -20°C. Protect from light. Stable for 24 months lyophilized.
04
Dosage200–500 mcg per administration in research models
05
FormatLyophilized
06
SourceSynthetic
07
SequenceGly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
08
CAS Number137525-51-0
09
Amino Acids15
10
Molecular Weight1419.53 g/mol
11
Molecular FormulaC₆₂H₉₈N₁₆O₂₂

Bulk Pricing

Volume Pricing Guide

QuantityPrice PerSavings
1$297
2 - 4$26710% off
5 - 9$25215% off
10 - 14$23820% off
15 - 19$22325% off
20+Best Value$20830% off

Quality Assurance

Certificate of Analysis

Certificate of Analysis

BatchDL8562
Purity99.0% (HPLC)
Test Date2024-12-23
LabDarmerica (Davie, FL)

Research Overview

About BPC-157

BPC-157 (Body Protection Compound-157) is a 15-amino-acid synthetic peptide derived from a protective protein found in human gastric secretions. Its remarkable stability within the gastrointestinal tract — unusual for a peptide of its size — has made it one of the most extensively studied regenerative compounds in contemporary preclinical literature.

At a molecular level, BPC-157 appears to orchestrate repair through multiple converging pathways: upregulation of vascular endothelial growth factor (VEGF) to drive angiogenesis, modulation of nitric oxide synthase activity, and acceleration of extracellular matrix remodeling at injury sites. These mechanisms have been documented across a diverse range of experimental injury models including tendon transection, ligament damage, muscle crush injuries, and gastrointestinal mucosal lesions.

ROEHN supplies BPC-157 at 99% HPLC-verified purity as a lyophilized powder, ensuring maximum stability and reproducibility for research protocols. This compound is frequently paired with TB-500 in preclinical studies investigating synergistic tissue repair through complementary signaling cascades.